摘要
目的探讨重组人促红细胞生成素(recombinant human erythropoietin,rhEPO)对6-羟基多巴胺(6-OHDA)诱导的SD大鼠帕金森病(PD)模型小胶质细胞活化的影响。方法 40只SD大鼠随机分为A组(rhEPO+6-OHDA)、B组(生理盐水+6-OHDA)、C组(6-OHDA)、D组(生理盐水),每组10只。(1)A组:右侧纹状体内立体定向注射重组促红细胞生成素(rhEPO),24h后同侧黒质内立体定向注射6-OHDA;(2)B组:右侧纹状体内立体定向注射与rhEPO等量的生理盐水,24h后同侧黒质内立体定向注射6-OHDA;(3)C组:右侧黒质内立体定向注射6-OHDA;(4)D组:右侧黒质内立体定向注射与6-OHDA等量的生理盐水。4w后采用免疫组化检测黒质内酪氨酸羟化酶(TH)阳性神经元和CD11b阳性细胞数量及CD11b阳性细胞形态变化。结果与D组比较,A组大鼠黒质TH阳性神经元明显减少,CD11b阳性细胞明显增多,大部分小胶质细胞胞体小,突起细长;与B组和C组比较,A组大鼠黒质TH阳性神经元显著增多,CD11b阳性细胞显著减少,仅有少量小胶质细胞胞体大,突起短粗。结论重组人促红细胞生成素(rhEPO)可能通过抑制小胶质细胞活化,减轻6-OHDA对多巴胺(DA)能神经元的毒性损害,对DA能神经元产生神经保护作用。
Objective To study the effects of recombinant human erythropoietin(rhEPO)on microglia in rat model of Parkinson's disease induced by 6-hydroxydopamine(6-OHDA).Methods Forty SD rats were randomly divided into four groups:A group(rhEPO+6-OHDA),B group(saline+6-OHDA),C group(6-OHDA)and D group(saline),ten average each group.Related manipulation:A group,ipsilateral substantia nigra(SN)stereotactic rejection of 6-OHDA on 24h after right striatum stereotactic rejection of rhEPO;B group,ipsilateral SN stereotactic rejection of 6-OHDA on 24h after right striatum stereotactic rejection of saline(equal quantity of rhEPO);C group,right SN stereotactic rejection of 6-OHDA;D group,right SN stereotactic rejection of saline(equal quantity of 6-OHDA).All groups were detected 4 weeks after the operation about the numbers of tyrosine hydroxylase(TH)positive neurons and morphological changes of CD11b positive cells in the SN by immunohistochemistry.Results Compared with D group,the number of TH+ neurons of SN reduced greatly in A group,the number of CD11b+ cells in SN increased markedly and most microglia showed small cell body with slim and long processes in A group.Compared with B and C group,the number of TH+ neurons in SN increased remarkably in A group,the number of CD11b+ cells of SN decreased markedly and only a few microglia showed big cell body with thicker shorter processes in A group.Conclusion Probably through blocking activation of microglia,rhEPO could prevent 6-OHDA-induced degeneration of DA neurons and protect DA neurons.
出处
《中风与神经疾病杂志》
CAS
CSCD
北大核心
2010年第11期992-994,共3页
Journal of Apoplexy and Nervous Diseases